Alternate dosing regimens of brentuximab vedotin for CD30+ cutaneous T-cell lymphoma

D. J. Lewis; Y. H. Kim; M. Duvic

doi:10.1111/bjd.15970

Alternate dosing regimens of brentuximab vedotin for CD30+ cutaneous T-cell lymphoma

D. J. Lewis, Y. H. Kim, M. Duvic

Dermatology

Research output: Contribution to journal › Letter › peer-review

4 Scopus citations

Original language	English (US)
Pages (from-to)	302-303
Number of pages	2
Journal	British Journal of Dermatology
Volume	178
Issue number	1
DOIs	https://doi.org/10.1111/bjd.15970
State	Published - Jan 2018

ASJC Scopus subject areas

Dermatology

Access to Document

10.1111/bjd.15970

Cite this

@article{c08eda9a99ff4cbca9626c082750ed51,

title = "Alternate dosing regimens of brentuximab vedotin for CD30+ cutaneous T-cell lymphoma",

author = "Lewis, {D. J.} and Kim, {Y. H.} and M. Duvic",

year = "2018",

month = jan,

doi = "10.1111/bjd.15970",

language = "English (US)",

volume = "178",

pages = "302--303",

journal = "British Journal of Dermatology",

issn = "0007-0963",

publisher = "Wiley-Blackwell",

number = "1",

}

TY - JOUR

T1 - Alternate dosing regimens of brentuximab vedotin for CD30+ cutaneous T-cell lymphoma

AU - Lewis, D. J.

AU - Kim, Y. H.

AU - Duvic, M.

PY - 2018/1

Y1 - 2018/1

UR - http://www.scopus.com/inward/record.url?scp=85040523122&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85040523122&partnerID=8YFLogxK

U2 - 10.1111/bjd.15970

DO - 10.1111/bjd.15970

M3 - Letter

C2 - 28889405

AN - SCOPUS:85040523122

SN - 0007-0963

VL - 178

SP - 302

EP - 303

JO - British Journal of Dermatology

JF - British Journal of Dermatology

IS - 1

ER -

Alternate dosing regimens of brentuximab vedotin for CD30+ cutaneous T-cell lymphoma

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this